Manufacturer record
Neutec Healthcare Pvt. Ltd. E-698: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Neutec Healthcare Pvt. Ltd. E-698 (Delhi) were declared Not of Standard Quality between August 2019 and April 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NT-17300, Dicyclomine Hydrochloride Tablets I.P.(Bargan) (exp Aug 2020). RDTL Guwahati (state lab) found it not of standard quality: Assay. Listed in the April 2020 alert.
Records by type
4 records linked to Neutec Healthcare Pvt. Ltd. E-698 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dicyclomine Hydrochloride Tablets I.P.(Bargan) | Batch NT-17300Mfg Sep 2017 · Exp Aug 2020 | AssayAssay | RDTL GuwahatiState lab | Apr 2020 |
| Ciprofloxacin & Tinidazole Tablets (CIPROTEC-TZ) | Batch CTZ-19001Mfg Aug 2019 · Exp Jul 2022 | DisintegrationDisintegration | RDTL GuwahatiState lab | Mar 2020 |
| Metronidazole Tablets I.P. 400mg. (NEUZOL- 400) | Batch NZL-19002Mfg May 2019 · Exp Apr 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2020 |
| Norfloxacin Tablets I.P. 400 mg (NORTEC-400) | Batch NTK-18004Mfg Mar 2019 · Exp Feb 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.